SynthesisEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2025
Duraplasty in acute spinal cord injury: a systematic review.
Synthesis in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Factors associated with hyponatremia in patients with acute spinal cord injury: a systematic review and meta-analysis.Frontiers in medicine · 2026Pooled it
- A fully implantable intraspinal microstimulation device for early preclinical evaluation of feasibility, stability, and functionality.Scientific reports · 2026Article
- Surgical Timing After Spinal Cord Injury: A Narrative Review of Current Evidence and Perspectives.Korean journal of neurotrauma · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute spinal cord injury (aSCI) can cause severe, lasting disabilities that may be fatal. Expansile duraplasty has been explored as a potential intervention aimed at alleviating spinal cord compression and enhancing neurological recovery in patients with aSCI.
objectiveThis systematic review aimed to assess efficacy, safety, and clinical outcomes of expansile duraplasty in the management of aSCI.
methodsThe literature was searched across major databases to identify relevant studies published up to July 2024. The inclusion criteria encompassed studies involving human subjects with aSCI that underwent duraplasty. Data extraction focused on neurological outcomes, complications, and follow-up duration.
resultsFour studies met the inclusion criteria, comprising a total of 158 patients with aSCI of which 35 patients underwent duraplasty. The average age of these patients was 50.2 years ± 15.5. Among these patients, 77.8% (123 patients) underwent decompression alone, while 22.2% (35 patients) underwent decompression combined with duraplasty. Improvements in the American Spinal Injury Association Impairment Scale (AIS) were reported in two studies, wherein 3/23 patients improved from grade A to grades C or D; 14/23 patients improved from grade B to grades C, D, or E; and 3/23 patients improved from grade C to grades D or E. Three studies detailed changes in spinal cord perfusion pressure indices, displaying significant improvement in intraspinal pressure, spinal cord perfusion pressure, and spinal cord pressure reactivity.
conclusionExpansile duraplasty shows promise in patients with aSCI and may be effective in enhancing patient outcomes. Current literature remains scarce and further studies need to be conducted.
Indexed as
Identifiers
40152995What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.